hVIVO engages in major phase 2b influeness drug study as exclusive UK clinical site
hVIVO plc (AIM & Euronext: HVO), a rapidly expanding specialist contract research organisation (CRO) renowned for its expertise in human challenge clinical trials for infectious ... Read More
Oncocross and JW Pharmaceutical forge new path in AI-driven drug development
In a significant stride toward revolutionizing drug discovery and development, Seoul-based biotech firm Oncocross announced on May 22nd a renewed joint research agreement with JW ... Read More
Bexion Pharmaceuticals advances BXQ-350 cancer drug trial with phase 1 part 3 launch
Bexion Pharmaceuticals has launched part 3 of its phase 1 clinical trial for BXQ-350, an investigational cancer treatment aimed at advancing the fight against solid ... Read More